US Market Report for Blood Glucose Test Strips 2017 – MedCore

PR Newswire

NEW YORK, Dec. 16, 2016 /PRNewswire/ --

Description
The U.S. blood glucose test strip market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total blood glucose test strip market was the personal segment. Personal test strips are used by individuals who use personal meters to perform self-monitoring of blood glucose (SMBG) on a daily basis. The personal test strip market is further segmented by insurance type and comprises the Medicare/Medicaid, managed care and cash sub-segments. CMS competitive bidding had a significant impact on the personal test strip market after substantial reimbursement cuts in July 2013 and July 2016, respectively. Professional test strips are used by clinicians and staff in the hospital or long term care settings to measure the blood glucose levels of their diabetic patients. Meters in the hospital are typically more technologically advanced than meters found in other settings and often involve software systems which analyze data and provide higher accuracy than personal meters. The growing number of individuals living in nursing homes or other long term care facilities who have diabetes will be the primary driver of market growth. However, as assisted living is becoming more popular, patients are opting for their own personal meters. Long term care centers are also starting to enforce 'one patient-one meter' policies, shifting the focus away from professional meters and test strips.
Abstract
Blood glucose test strips are thin strips with enzymes that react to blood droplets. These create either a photometric or electrochemical response which is read by a glucose meter. Strips vary by size, chemical makeup, fluid channels, etc. and are typically sold in containers of 50 or 100. A single strip is used for each test, and some brands have preloaded strip storage within their meters. Electrochemical strips are the most popular type, largely due to the extremely small volumes of blood required to measure glucose. These strips function by working with the blood glucose meter to produce an electrical current, which is proportional to the blood glucose concentration. Several different enzymes may be used for transferring electrons from the glucose in the blood to the electrode. Typically, the current can be measured between 5 and 15 seconds.
Scope:2013-2023
Companies
Sanofi
Novo Nordisk
Eli Lilly
Medtronic
Johnson & Johnson
Becton Dickinson
Abbott
Roche
DexCom
Ascensia
Insulet
Trividia Health
Tandem
Nova Biomedical
Valeritas
Read the full report: http://www.reportlinker.com/p04353018-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/us-market-report-for-blood-glucose-test-strips-2017---medcore-300380174.html